Tatva Chintan Pharma Quarterly Results for Trading Insights
TATVA • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹10 Cr
QSept 2025
Tatva Chintan Pharma Quarterly Results Key Highlights
- Revenue of ₹125 Cr in Sept 2025 (+14.7% vs Mar 2025, +48.8% vs Sept 2024)
- Net Profit of ₹10 Cr in Sept 2025 (+900.0% vs Mar 2025, +1100.0% vs Sept 2024)
- EBITDA of ₹23 Cr in Sept 2025 (+130.0% vs Mar 2025)
- Operating Margin of 18.0% in Sept 2025 (+10.0pp vs Mar 2025)
- Earnings Per Share of ₹4.24 in Sept 2025 (+863.6% vs Mar 2025)
Tatva Chintan Pharma Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 125 | 109 | 118 | 84 | 103 | 14.7% | 48.8% |
| Net Profit (₹ Cr) | 10 | 1 | 7 | -1 | 10 | - | - |
| EBITDA (₹ Cr) | 23 | 10 | 19 | 6 | 20 | - | - |
| EPS (₹) | 4.24 | 0.44 | 2.84 | -0.29 | 4.11 | - | - |
| Operating Margin (%) | 18.0% | 8.0% | 15.0% | 7.0% | 16.0% | - | - |
Tatva Chintan Pharma Share Price Trend Around Quarterly Results
Visualize Tatva Chintan Pharma's 1-year price movement across quarterly results — ideal for logging trades in Tatva Chintan Pharma share price
chart using Tickjournal. All values in ₹.
Related Pages for Tatva Chintan Pharma
Additional stock information and data for TATVA
Revenue Trend (₹ Cr)
Sept 2024
84
Jun 2025
118
Mar 2025
109
Sept 2025
125
Net Profit Trend (₹ Cr)
Sept 2024
-1
Jun 2025
7
Mar 2025
1
Sept 2025
10
Operating Margin Trend (%)
Sept 2024
7.0%
Jun 2025
15.0%
Mar 2025
8.0%
Sept 2025
18.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Tatva Chintan Pharma quarterly results with other companies in Chemicals sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Pidilite Industries
Sept 2025 |
₹153,165.96 Cr | 1505.0 | 3,605 | 585 | +11.9% | - | 16.2% | 264.5 |
|
SRF
Sept 2025 |
₹90,062.75 Cr | 3051.4 | 3,560 | 388 | -16.2% | - | 10.9% | 232.9 |
|
Coromandel Internat…
Sept 2025 |
₹68,365.19 Cr | 2312.9 | 9,771 | 793 | +78.9% | - | 8.1% | 84.6 |
|
UPL
Sept 2025 |
₹67,916.68 Cr | 799.3 | 12,411 | 612 | -20.8% | - | 4.9% | 118.4 |
|
Fertilisers & Chemi…
Sept 2025 |
₹56,838.80 Cr | 878.4 | 1,681 | 21 | +48.8% | - | 1.2% | 2745.0 |
Sector Quarterly Performance Comparison
Chemicals sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores